TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16)
-
Published:2024-02
Issue:
Volume:
Page:113588
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Colombo IlariaORCID,
Koster Kira-LeeORCID,
Holer Lisa,
Haefliger SimonORCID,
Rabaglio ManuelaORCID,
Bastian Sara,
Schwitter Michael,
Eckhardt Katrin,
Hayoz StefanieORCID,
Mc Laughlin Anna M.,
Kloft Charlotte,
Klose MarianORCID,
Halbherr StefanORCID,
Baumgartner Christian,
Sessa Cristiana,
Stathis Anastasios,
Hess DagmarORCID,
Joerger MarkusORCID
Subject
Cancer Research,Oncology